ImCheck Therapeutics' Unattributed Round

ImCheck Therapeutics raised a round of funding on October 09, 2017. Investors include BPI France.

ImCheck Therapeutics is a Marseille-based company developing next generation immuno-modulatory antibodies acting on both adaptive and innate immunity (notably gamma-delta T-cells) for the treatment of…

Articles about ImCheck Therapeutics' Unattributed Round: